微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 38.88% | -3.63% | -2.05% | 28/51 | 35.76% | 南华生物 | 68.03% | 行业排名> |
| 2024-06-30 | 39.69% | -0.54% | 4.92% | 24/51 | 35.89% | 百诚医药 | 68.75% | 行业排名> |
| 2024-03-31 | 37.83% | -4.58% | -1.93% | 27/51 | 35.75% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 38.58% | -2.67% | -4.38% | 29/51 | 38.13% | 药康生物 | 67.61% | 行业排名> |
| 2023-09-30 | 40.34% | 0.57% | 1.08% | 27/51 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 39.91% | 0.54% | 0.66% | 27/51 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 39.65% | 2.12% | 0.03% | 26/51 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 39.64% | -8.99% | -1.19% | 31/51 | 40.1% | 药康生物 | 71.38% | 行业排名> |
| 2022-09-30 | 40.11% | -14.22% | 1.04% | 29/51 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 39.7% | -16.54% | 2.24% | 30/51 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 38.83% | -17.25% | -10.85% | 28/51 | 38.57% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 43.55% | -8.18% | -6.87% | 24/51 | 41.94% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 46.77% | -3.54% | -1.68% | 19/51 | 43.07% | 南华生物 | 84.53% | 行业排名> |
| 2021-06-30 | 47.57% | -1.83% | 1.38% | 18/51 | 42.6% | 南华生物 | 83.19% | 行业排名> |
| 2021-03-31 | 46.92% | 1.47% | -1.08% | 13/51 | 39.47% | 南华生物 | 83.9% | 行业排名> |
| 2020-12-31 | 47.43% | 2.06% | -2.16% | 18/51 | 38.51% | 成都先导 | 79.36% | 行业排名> |
| 2020-09-30 | 48.48% | 3.37% | 0.06% | 8/51 | 37.76% | 成都先导 | 75.92% | 行业排名> |
| 2020-06-30 | 48.46% | 1.9% | 4.79% | 13/51 | 39.28% | 南华生物 | 78.74% | 行业排名> |
| 2020-03-31 | 46.24% | 3.49% | -0.51% | 10/51 | 33.2% | 成都先导 | 80.82% | 行业排名> |
| 2019-12-31 | 46.48% | 7.82% | -0.9% | 16/51 | 42.94% | 成都先导 | 81.55% | 行业排名> |
| 2019-09-30 | 46.9% | 9.93% | -1.37% | 13/51 | 44.61% | 海特生物 | 84.37% | 行业排名> |
| 2019-06-30 | 47.55% | 3.76% | 6.42% | 12/51 | 45.09% | 海特生物 | 87.74% | 行业排名> |
| 2019-03-31 | 44.68% | -0.55% | 3.66% | 12/51 | 43.51% | 海特生物 | 88.04% | 行业排名> |
| 2018-12-31 | 43.11% | 0.39% | 1.04% | 21/51 | 42.09% | 海特生物 | 92.52% | 行业排名> |
| 2018-09-30 | 42.66% | -1.06% | -6.91% | 16/51 | 43.61% | 海特生物 | 94.18% | 行业排名> |
| 2018-06-30 | 45.83% | 6.21% | 2.01% | 16/51 | 43.98% | 海特生物 | 94.39% | 行业排名> |
| 2018-03-31 | 44.93% | 4.97% | 4.63% | 14/51 | 45.58% | 海特生物 | 94.57% | 行业排名> |
| 2017-12-31 | 42.94% | 12.92% | -0.42% | 15/51 | 40.94% | 退市海医 | 87.54% | 行业排名> |
| 2017-09-30 | 43.12% | 5.58% | -0.07% | 14/51 | 44.64% | 海特生物 | 95.31% | 行业排名> |
| 2017-06-30 | 43.15% | 3.9% | 0.81% | 14/51 | 43.6% | 退市海医 | 91.85% | 行业排名> |
| 2017-03-31 | 42.8% | -2.29% | 12.56% | 10/51 | 38.7% | 海特生物 | 95.45% | 行业排名> |
| 2016-12-31 | 38.03% | -13.81% | -6.89% | 19/51 | 40.43% | 退市海医 | 96.32% | 行业排名> |
| 2016-09-30 | 40.84% | -13% | -1.65% | 9/51 | 37.08% | 海特生物 | 95.35% | 行业排名> |
| 2016-06-30 | 41.53% | -12.33% | -5.19% | 9/51 | 33.77% | 退市海医 | 95.27% | 行业排名> |
| 2016-03-31 | 43.81% | -3.86% | -0.72% | 7/51 | 28.42% | 盈康生命 | 75.69% | 行业排名> |
| 2015-12-31 | 44.12% | -6.76% | -6.02% | 13/51 | 37.17% | 海特生物 | 95.38% | 行业排名> |
| 2015-09-30 | 46.95% | -2.63% | -0.9% | 4/51 | 33.25% | 药石科技 | 67.7% | 行业排名> |
| 2015-06-30 | 47.37% | -5.77% | 3.96% | 4/51 | 32.07% | 药石科技 | 66.33% | 行业排名> |
| 2015-03-31 | 45.57% | -7.51% | -3.71% | 5/51 | 24.2% | 睿智医药 | 52.68% | 行业排名> |
| 2014-12-31 | 47.32% | 4.98% | -1.85% | 7/51 | 35.91% | 海特生物 | 95.14% | 行业排名> |
| 2014-09-30 | 48.22% | 7.1% | -4.09% | 2/51 | 31.52% | 皓宸医疗 | 52.16% | 行业排名> |
| 2014-06-30 | 50.27% | 9.68% | 2.04% | 2/51 | 30.64% | 皓宸医疗 | 55.65% | 行业排名> |
| 2014-03-31 | 49.27% | 2.81% | 9.3% | 2/51 | 31.6% | 新里程 | 53.57% | 行业排名> |